期刊文献+

速率比浊法测定13价肺炎球菌结合疫苗中的各型多糖含量 被引量:5

Determination of polysaccharide contents in 13-valent pneumococcal conjugated vaccine by nephelometry
原文传递
导出
摘要 目的:建立速率比浊法检测13价肺炎球菌结合疫苗各型多糖含量。方法:采用免疫化学系统(IMMAGE 800),选择非竞争性浊度模式,样品或标准品20μL,血清20μL,反应缓冲液200μL,增益系数为4,反应时间为2.5 min;用氢氧化钠解吸附法处理样品和标准品。结果:在本文条件下,1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、23F型肺炎球菌荚膜多糖浓度在1~6μg·mL^-1检测范围内,线性良好(r〉0.99);重复性RSD均低于7%;各型多糖含量回收率在70%~130%;专属性考察结果显示,除9N型多糖的存在会干扰9V型多糖含量检测外,13价肺炎球菌结合疫苗中不包含的多糖(2、8、10A、11A、12F、15B、17F、20、22F、33F型)对此方法没有影响;耐用性研究结果显示,氢氧化钠解吸附法处理样品和标准品时,控制在10 s左右即中和解吸附过程中加入的氢氧化钠;用所建立速率比浊法检测13价肺炎球菌结合疫苗中的1、3、4、5、6A、6B、7F、9V、14、18C、19A、19F、23F型肺炎球菌荚膜多糖含量,结果显示4批成品检测值在理论值的70%~130%之间。结论:所建立的检测方法准确,重复性好,可作为13价肺炎球菌结合疫苗的质控标准。 Objective: To establish anephelometry method for the determination of the polysaccharides contents in the 13- valent pneumococcal conjugated vaccine. Methods: Using immunochemistry system,the non- competitive nephelometric protocol was chosen,the volume of the sample or the standard substance was 20 μL,the serum volume 20 μL,the reaction buffer volume 200 μL,the gain factor 4,the reaction time 2. 5 minutes. The sample or the standard substance was treated by sodium hydroxide desorption. Results: Under these conditions in this study,linear relationships of the 1,3,4,5,6A,6B,7F,9V,14,18 C,19A,19 F,23F pneumococcal capsular polysaccharides in the range of 1- 6 μg·mL^-1 were good,r 〉0. 99. The RSD of repeatability was lower than 7%. The recoveries of 13 types of polysaccharides were 70%- 130%. The specificity results showed that 9N polysaccharide had influence on the detection of 9V polysaccharide contents,while the polysaccharides( 2,8,10 A,11A,12 F,15B,17 F,20,22 F and33F) that were not contained in the 13- valent pneumococcal conjugated vaccine had no influence. Robustness study results showed that using sodium hydroxide to treat samples and standard substances,Na OH added during the adsorbent process could be neutralized in 10 seconds. Using the nephelometry method to determinate the contents of1,3,4,5,6A,6B,7F,9V,14,18 C,19A,19 F,23F serotype of pneumococcal capsular polysaccharides in the 13-valent pneumococcal conjugated vaccine,the results showed that in 4 batches of products the measured values were between 70%- 130% of theoretical values. Conclusion: This method is accurate and feasible. It provides a reference for the quality control of the 13- valent pneumococcal conjugated vaccine.
出处 《药物分析杂志》 CAS CSCD 北大核心 2014年第11期1954-1958,共5页 Chinese Journal of Pharmaceutical Analysis
基金 国家高技术研究发展计划(863计划):疫苗效果和质量评价新技术研究(课题编号:2012AA02A402)
关键词 速率比浊法 13价肺炎球菌结合疫苗 肺炎球菌荚膜多糖含量 非竞争性浊度模式 氢氧化钠解吸附法 nephelometry 13-valent pneumococcal conjugated vaccine pneumococcal capsular polysaccharide contents non-competitive nephelometric protocol sodium hydroxide desorption
  • 相关文献

参考文献12

  • 1Patrick R,Murray PR,Baron EJ, et al. Manual of Clinical Microbiology.Vol 1[M]. 9th ed. Washington DC:American Society for Microbiology,2007.
  • 2Yao KH,Yang YH. Streptococcus pneumoniae diseases in Chinese children:past,present and future[J].Vaccine,2008,26(35):4425.
  • 3O'Brien KL,Wolfson LJ,Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years:global estimates[J].Lancet,2009,374(9693):893.
  • 4Pneumococcal conjugate vaccine for childhood immunization-WHO position paper[R]. Wkly Epidemiol Rec,2007,82(12):93.
  • 5Miller E,Andrews N,Waight P, et al. Bacterial infections,immune overload,and MMR vaccine. Measles,mumps,and rubella[J].Arch Dis Child,2003,88(3):222.
  • 6Hansen J,Black S,Shinefield H, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia:updated analysis using World Health Organization standardized interpretation of chest radiographs[J].PediatrInf Dis J,2006,25(9):779.
  • 7MacIntyre CR,Egerton T,McCaughey M, et al. Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old[J].Hum Vaccin,2010,6(11):894.
  • 8Thorburn AN,O'Sullivan BJ,Thomas R, et al. Pneumococcal conjugate vaccine-induced regulatory T cells suppress the development of allergic airways disease[J].Thorax,2010,65(12):1053.
  • 9CDC. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States,1998-2003[J].MMWR,2005,54(36):893.
  • 10陈琼,石继春,王春娥,王珊珊,叶强.不同解吸附处理对肺炎球菌结合疫苗各型多糖含量检测结果的影响[J].中国生物制品学杂志,2013,26(8):1170-1174. 被引量:5

二级参考文献4

  • 1陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:605
  • 2Yao KH, Yang YH. Streptococcus pneumoniae diseases in China children: past, present and future [J]. Vaccine, 2008, 26 (35): 4425-4433.
  • 3Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneu- mocoecal disease-United States,1998-2003 [J]. MMWR Morb Mortal Wkly Rep, 2005, 54 (36): 893-897.
  • 4湛琳丽,温昊,祝明,马金花,徐爱平.铝佐剂的特性及影响因素[J].畜牧市场,2009(5):13-15. 被引量:7

共引文献4

同被引文献18

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部